Medicines Company hires Parkin as senior VP of international operations

Glyn R. Parkin has joined the Medicines Company as senior vice president of international operations responsible for the design, implementation and leadership of the international organization.

He will be responsible for the establishment of functioning, capable organizations and business operations in new territories, and then transitioning the operations to the current business unit structure of the organization, according to the Parsippany, N.J.-based company.

Parkin was with Eli Lilly for more than 25 years, where he served as executive director marketing and oversaw European operations of the Lilly Europe executive leadership team as well as marketing, Medicines Company said. He previously held U.K. sales and marketing leadership positions, and spent eight years in Indiana ,where he served as global marketing director for Lilly Diabetes Care and led their neuroscience division.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.